• Seeking Alpha

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

Seeking Alpha / 7 hours ago 2 Views

IN8bio Expands INB-100 Phase 1 Clinical Trial with addition of The Ohio State University as New Site
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
NEXE Innovations Reports Repeat and New Orders: ~250K Repeat Order and 100K New West Coast Roaster Deal
Next post
CHAR Tech Invited to Join the Canadian Iron & Steel Energy Research Association (CISERA)

Comments

Just Posted

  • DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq

    3 hours from now

  • DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

    3 hours from now

  • Allied Announces Third-Quarter Results

    3 hours from now

  • NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries

    3 hours from now

  • GFG Upsizes Flow-Through Private Placement

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1595

Categories

  • Seeking Alpha 1595

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts